Cargando…

Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning

OBJECTIVES: To identify patient- and disease-related characteristics that make it possible to predict higher disease severity in recent-onset PsA. METHODS: We performed a multicenter observational prospective study (2-year follow-up, regular annual visits). The study population comprised patients ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Queiro, Rubén, Seoane-Mato, Daniel, Laiz, Ana, Galindez Agirregoikoa, Eva, Montilla, Carlos, Park, Hye Sang, Pinto Tasende, Jose A., Bethencourt Baute, Juan José, Joven Ibáñez, Beatriz, Toniolo, Elide, Ramírez, Julio, Pruenza García-Hinojosa, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097678/ https://www.ncbi.nlm.nih.gov/pubmed/35572968 http://dx.doi.org/10.3389/fmed.2022.891863

Ejemplares similares

Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
por: Queiro, Rubén, et al.
Publicado: (2023)

Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
por: Queiro, Rubén, et al.
Publicado: (2022)

The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review
por: Cañete, Juan D., et al.
Publicado: (2020)

Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
por: Valero-Martínez, Cristina, et al.
Publicado: (2023)

Management of particular clinical situations in psoriatic arthritis: an expert’s recommendation document based on systematic literature review and extended Delphi process
por: García-Vicuña, Rosario, et al.
Publicado: (2021)

Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
por: Queiro, Rubén, et al.
Publicado: (2017)

Commentary: Sex-based medicine in psoriatic arthritis: Lessons learned from machine learning-based prediction models
por: Queiro, Rubén
Publicado: (2022)

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis
por: Queiro, Rubén, et al.
Publicado: (2021)

Obesity in psoriatic arthritis: Comparative prevalence and associated factors
por: Queiro, Rubén, et al.
Publicado: (2019)

HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis
por: Queiro, Ruben, et al.
Publicado: (2006)

Evaluating standards of care in psoriatic arthritis of the QUANTUM project (qualitative initiative to improve outcomes): results of an accreditation project in Spain
por: García, Emilio Ignacio, et al.
Publicado: (2020)

Genetic Variants of the NF-κB Pathway: Unraveling the Genetic Architecture of Psoriatic Disease
por: Queiro, Rubén, et al.
Publicado: (2021)

Uveitis in psoriatic arthritis: study of 406 patients in a single university center and literature review
por: De Vicente Delmás, Ana, et al.
Publicado: (2023)

Gene Variant in the NF-κB Pathway Inhibitor NFKBIA Distinguishes Patients with Psoriatic Arthritis within the Spectrum of Psoriatic Disease
por: Coto-Segura, Pablo, et al.
Publicado: (2019)

Non-Physical Disease Facets in Spondyloarthritis: An ASAS Health Index-Based Analysis between Psoriatic Arthritis and Axial Spondyloarthritis
por: Queiro, Rubén, et al.
Publicado: (2022)

Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
por: Eder, Lihi, et al.
Publicado: (2022)

Potential Differences in the Cardiometabolic Risk Profile of Patients with Psoriatic Disease according to Their HLA-C∗06 Status
por: Queiro, Rubén, et al.
Publicado: (2022)

Clinical Differences between Men and Women with Psoriatic Arthritis: Relevance of the Analysis of Genes and Polymorphisms in the Major Histocompatibility Complex Region and of the Age at Onset of Psoriasis
por: Queiro, Rubén, et al.
Publicado: (2013)

The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
por: Navarro-Compán, Victoria, et al.
Publicado: (2023)

Higher prevalence of psoriatic arthritis in the adult population in Spain? A population-based cross-sectional study
por: Romero Pérez, Antonio, et al.
Publicado: (2020)

Treatment Retention and Safety of Ixekizumab in Psoriatic Arthritis: A Real Life Single-Center Experience
por: Braña, Ignacio, et al.
Publicado: (2023)

Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
por: Pinto Tasende, Jose A., et al.
Publicado: (2023)

Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study
por: Queiro, Ruben, et al.
Publicado: (2020)

The Region Centromeric to HLA-C Is a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis
por: Queiro, Rubén, et al.
Publicado: (2014)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
por: Alonso, Sara, et al.
Publicado: (2021)

Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey
por: Lim, Irwin, et al.
Publicado: (2021)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey
por: Richette, Pascal, et al.
Publicado: (2022)

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
por: Mease, Philip J., et al.
Publicado: (2020)

Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis
por: Helliwell, Philip, et al.
Publicado: (2014)

COVID-19: What's next?()
por: Díaz Tasende, José
Publicado: (2020)

COVID-19: ¿y ahora qué?
por: Díaz Tasende, José
Publicado: (2020)

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis
por: Siebert, Stefan, et al.
Publicado: (2022)

Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
por: Coates, L. C., et al.
Publicado: (2020)

Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey
por: Coates, Laura C., et al.
Publicado: (2021)

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
por: Van Kuijk, Arno W R, et al.
Publicado: (2023)

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
por: Smolen, Josef S, et al.
Publicado: (2021)

Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
por: Gossec, Laure, et al.
Publicado: (2023)

Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study
por: Gossec, Laure, et al.
Publicado: (2022)

Bilateral Granulomatous Iridocyclitis Associated with Early-Onset Juvenile Psoriatic Arthritis
por: Nieves-Ríos, Christian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ole9dkfgb1mmmguajeds58h05d